Kidney-On-Chip and Organoid Models
Journal of the American Society of Nephrology · 08.09.2026
DOI: 10.1681/asn.0000001272 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, online erschienen am 08.09.2026. Verfasst von Abigail Daily und 4 weiteren Autor:innen. Beteiligte Einrichtung: Barbara T. Murphy Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 102 Literaturangaben. Gefördert von: NIDDK NIH HHS, US Department of Defense, NCATS NIH HHS.
Abstract (Originalsprache)
The US Food and Drug Administration Modernization Act and the federal policy changes in 2025 have signaled a shift toward the use of nonanimal, human-centered models for preclinical drug development and toxicity screening, emphasizing 3D cell-based, organ-on-chip, and organoid platforms as alternatives to animal models. While animal models have advanced our understanding of disease mechanisms, they do not allow decoupling of biomechanical and biochemical effects during pathogenesis. I n vitro systems offer improved accessibility but lack physiologically relevant microenvironments. In this review, we discuss how kidney-on-chip and induced pluripotent stem cell–derived kidney organoid models serve as physiologically relevant platforms for modeling nephrotoxicity, kidney development, and pathophysiology. Kidney-on-chip models recapitulate in vivo mechanical forces, such as fluid shear stress and mechanical strain, experienced by cells, enabling real-time functional readouts of glomerular filtration, tubular reabsorption, and nephrotoxic response. Integrating on-chip platforms with patient-derived induced pluripotent stem cells and differentiated kidney cell types allows human-relevant responses unavailable in static culture. Induced pluripotent stem cell–derived kidney organoids recapitulate the 3D architecture of nephron segments and ureteric bud branching patterns, demonstrating selective transport, toxicity responses, and structural stability over months in culture. We detail how bioengineering approaches, including organoid-on-chip models, bioprinting, and multi–organ-on-chip integration, could address the limitations of organoids, such as maturity, scalability, and vascularization. We discuss how integrating publicly available clinical databases and machine learning approaches with on-chip validation can improve translational relevance. We conclude that interdisciplinary collaboration between engineers, biologists, and physician scientists remains essential to translating bioengineered kidney models into clinical and therapeutic applications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Barbara T. Murphy Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York.
- Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
- Windreich Department of Artificial Intelligence and Human Health, Icahn School of Medicine at Mount Sinai, New York, New York.
ORCID-Profile: Abigail Daily, Nanditha Anandakrishnan, Jonathan Haydak, Jonathan Himmelfarb
Förderung
- NIDDK NIH HHS
- US Department of Defense
- NCATS NIH HHS
- NIGMS NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Center for Advancing Translational Sciences
- National Institute of General Medical Sciences
Zitieren
APA
Daily, A., Anandakrishnan, N., Haydak, J., Himmelfarb, J., & Azeloglu, E. U. (2026). Kidney-On-Chip and Organoid Models. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.0000001272
Vancouver
Daily A, Anandakrishnan N, Haydak J, Himmelfarb J, Azeloglu EU. Kidney-On-Chip and Organoid Models. Journal of the American Society of Nephrology. 2026. doi:10.1681/asn.0000001272
BibTeX
@article{Daily2026,
author = {Daily, Abigail and Anandakrishnan, Nanditha and Haydak, Jonathan and Himmelfarb, Jonathan and Azeloglu, Evren U},
title = {Kidney-On-Chip and Organoid Models},
journal = {Journal of the American Society of Nephrology},
year = {2026},
doi = {10.1681/asn.0000001272}
}
EUVIMED